ArticleFrontiers in immunology2025

Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection.

Zdzisława Kondera-Anasz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.